Professor Stuart McPherson
Dr Jess Dyson
Dr Laura Jopson
Dr Steven Masson
Professor Quentin Anstee
et al. | How effective are experienced hepatologists at staging fibrosis using non-invasive fibrosis tests in patients with metabolic dysfunction-associated steatotic liver disease? | 2024 |
|
Professor Stuart McPherson
Dr Jess Dyson
Dr Laura Jopson
Dr Steven Masson
Professor Quentin Anstee
et al. | Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2-F3 fibrosis. Authors' reply | 2024 |
|
Dr Jenny Gallacher
Dr Laura Jopson
Dr Dina Mansour
Professor Stuart McPherson
| Improved outcomes following the implementation of a decompensated cirrhosis discharge bundle | 2022 |
|
Dr Aaron Wetten
Dr Laura Ogle
Dr George Mells
Dr Vinod Hegade
Dr Laura Jopson
et al. | Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis? | 2022 |
|
Professor David Jones
Dr Aaron Wetten
Dr Ben Barron-Millar
Dr Laura Ogle
Dr George Mells
et al. | The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study | 2022 |
|
Dr Laura Jopson
Dr Stephanie Needham
| Curious case of gut dysmotility | 2021 |
|
Dr Laura Jopson
Professor David Jones
| Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison | 2021 |
|
Dr Ben Barron-Millar
Dr Laura Ogle
Emeritus Professor John Kirby
Dr Jeremy Palmer
Dr Laura Jopson
et al. | The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis | 2021 |
|
Dr Amardeep Khanna
Dr Laura Jopson
Denise Howel
Andrew Bryant
Professor Andrew Blamire
et al. | Rituximab is Ineffective for Treatment of Fatigue in Primary Biliary Cholangitis: A Phase-2 Randomised Controlled Trial | 2019 |
|
Dr Laura Jopson
Dr Amardeep Khanna
Professor David Jones
| Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness | 2018 |
|
Dr Amardeep Khanna
Dr Laura Jopson
Denise Howel
Andrew Bryant
Professor Andrew Blamire
et al. | Rituximab for the Treatment of Fatigue in Primary Biliary Cholangitis (formerly Primary Biliary Cirrhosis) A Randomised Controlled Trial | 2018 |
|
Dr Laura Jopson
Professor David Jones
| Fatigue in Primary Biliary Cirrhosis: Prevalence, Pathogenesis and Management | 2015 |
|
Kile Green
Sarah Pagan
Dr Jess Dyson
Dr Lucy Walker
Dr Laura Jopson
et al. | High-risk primary biliary cirrhosis has a distinct molecular signature opening the way for a molecular approach to stratified therapeutics | 2015 |
|
Dr Laura Jopson
Dr Vinod Hegade
Professor David Jones
| Natural history of fatigue and pruritus in primary biliary cirrhosis: Implications for the role of pruritus in the aetiology and treatment of fatigue | 2015 |
|
Dr Jess Dyson
Dr Laura Jopson
Professor Stuart McPherson
| Rituximab and hepatitis B: are we doing it right? | 2015 |
|
